Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Maitreya Medica.
Quarter-by-quarter operating performance
Financials of Maitreya Medica.
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| Sales + | 55.93 | 49.35 | 39.28 | 46.08 | 44.98 | 46.00 |
| Expenses + | 48.68 | 45.98 | 32.02 | 40.08 | 40.10 | 43.28 |
| Operating Profit | 7.25 | 3.37 | 7.26 | 6.00 | 4.88 | 2.72 |
| OPM % | 12.96% | 6.83% | 18.48% | 13.02% | 10.85% | 5.91% |
| Other Income + | 0.43 | 0.33 | 0.53 | 0.30 | 0.57 | 0.63 |
| Interest | 0.82 | 0.78 | 0.57 | 0.84 | 0.80 | 0.78 |
| Depreciation | 1.09 | 1.32 | 1.29 | 1.27 | 1.44 | 1.57 |
| Profit before tax | 5.77 | 1.60 | 5.93 | 4.19 | 3.21 | 1.00 |
| Tax % | 26.52% | 28.75% | 28.16% | 29.12% | 41.74% | |
| Net Profit + | 4.24 | 1.14 | 4.25 | 2.97 | 1.87 | 0.16 |
| EPS in Rs | 4,240.00 | 1,140.00 | 8.57 | 4.38 | 2.76 | 0.24 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials of Maitreya Medica.
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 4.96 | 6.78 | 6.78 | 11.55 |
| Reserves | 3.85 | 4.70 | 3.81 | 18.07 | 19.94 | 19.91 |
| Borrowings + | 14.24 | 12.38 | 11.59 | 11.10 | 10.53 | 4.28 |
| Other Liabilities + | 7.17 | 7.40 | 8.55 | 7.91 | 10.75 | 13.48 |
| Total Liabilities | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 49.22 |
| Fixed Assets + | 13.84 | 13.40 | 11.60 | 14.32 | 15.26 | 16.31 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.07 | 0.32 | 0.68 | 1.47 | 0.04 | 0.04 |
| Other Assets + | 10.36 | 10.77 | 16.63 | 28.07 | 32.70 | 32.87 |
| Total Assets | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 49.22 |
Financials of Maitreya Medica.
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | 4.45 | 0.08 | 2.59 | -2.50 | 5.06 |
| Cash from Investing Activity + | -5.07 | -0.02 | 0.36 | -5.44 | -7.37 |
| Cash from Financing Activity + | 2.16 | -1.86 | -1.59 | 12.21 | 3.67 |
| Net Cash Flow | 1.55 | -1.80 | 1.36 | 4.27 | 1.36 |
| Free Cash Flow | -1.17 | -0.82 | 3.16 | -4.11 | 2.68 |
| CFO/OP | 77% | 54% | 40% | -12% | 134% |
Financials of Maitreya Medica.
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 31.91 | 43.42 | 90.41 | 108.52 | 121.40 |
| Inventory Days | 68.78 | 40.82 | 69.86 | 40.26 | 36.56 |
| Days Payable | 258.06 | 221.84 | 319.59 | 207.25 | 199.54 |
| Cash Conversion Cycle | -157.37 | -137.61 | -159.32 | -58.47 | -41.58 |
| Working Capital Days | -4.11 | 3.11 | 43.12 | 73.43 | 73.68 |
| ROCE % | 12.33% | 32.85% | 17.30% | 10.77% |